Your browser doesn't support javascript.
loading
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Kudo, Masatoshi; Ueshima, Kazuomi; Ikeda, Masafumi; Torimura, Takuji; Tanabe, Nobukazu; Aikata, Hiroshi; Izumi, Namiki; Yamasaki, Takahiro; Nojiri, Shunsuke; Hino, Keisuke; Tsumura, Hidetaka; Kuzuya, Teiji; Isoda, Norio; Yasui, Kohichiroh; Aino, Hajime; Ido, Akio; Kawabe, Naoto; Nakao, Kazuhiko; Wada, Yoshiyuki; Yokosuka, Osamu; Yoshimura, Kenichi; Okusaka, Takuji; Furuse, Junji; Kokudo, Norihiro; Okita, Kiwamu; Johnson, Philip James; Arai, Yasuaki.
Affiliation
  • Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan m-kudo@med.kindai.ac.jp.
  • Ueshima K; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Torimura T; Department of Gastroenterology and Hepatology, Kurume University School of Medicine, Kurume, Japan.
  • Tanabe N; Department of Gastroenterology, National Hospital Organisation Sendai Medical Center, Sendai, Japan.
  • Aikata H; Department of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan.
  • Izumi N; Department of Gastroenterology, Musashino Red Cross Hospital, Tokyo, Japan.
  • Yamasaki T; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Ube-Yamaguchi, Japan.
  • Nojiri S; Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Hino K; Department of Hepatology and Pancreatology, Kawasaki Medical School, Kurashiki, Japan.
  • Tsumura H; Department of Gastroenterology and Hepatology, Hyogo Cancer Center, Akashi, Japan.
  • Kuzuya T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Isoda N; Department of Medicine, Division of Gastroenterology, Jichi Medical University, Shimotsuke, Japan.
  • Yasui K; Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Aino H; Division of Gastroenterology, Department of Medicine, Social Insurance Tagawa Hospital, Tagawa, Japan.
  • Ido A; Department of Gastroenterology and Hepatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Kawabe N; Department of Liver, Biliary Tract and Pancreas Diseases, Fujita Health University School of Medicine, Aichi, Japan.
  • Nakao K; Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Wada Y; Department of Hepato-Biliary-Pancreatic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Yokosuka O; Department of Gastroenterology, School of Medicine, Chiba University, Chiba, Japan.
  • Yoshimura K; Center for Integrated Medical Research, Hiroshima University, Hiroshima, Japan.
  • Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Furuse J; Department of Medical Oncology, Kyorin University Faculty of Medicine, Mitaka, Japan.
  • Kokudo N; Department of Surgery, National Center for Global Health and Medicine, Tokyo, Japan.
  • Okita K; Deapartment of Medicine, Shunan Memorial Hospital, Kudamatsu, Yamaguchi, Japan.
  • Johnson PJ; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Arai Y; Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
Gut ; 69(8): 1492-1501, 2020 08.
Article in En | MEDLINE | ID: mdl-31801872
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Sorafenib / Liver Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Sorafenib / Liver Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article